Phase I study of HP-3070 in patients with schizophrenia.
Phase 1
- Conditions
- schizophrenia
- Registration Number
- JPRN-jRCT1080222475
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Subjects who meet the diagnostic criteria for schizophrenia or schizoaffective disorder according to the DSM-IV-TR for at least 1 year before screening.
Exclusion Criteria
- Subjects who have an active DSM-IV-TR axis I diagnosis other than schizophrenia or schizoaffective disorder.
- Subjects who have a history of substance dependence within 6 months before screening or alcoholism.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method